ClinicalTrialsFinder
RecruitingNot ApplicableNCT07061613

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers

Evaluating the Efficacy and Safety of NeoThelium FT Amnion Skin Graft in the Management of Venous Leg Ulcers: A Prospective Case Series

Sponsor

NuScience Medical Biologics, LLC

Enrollment

10 participants

Start Date

Sep 2, 2025

Study Type

INTERVENTIONAL

Conditions

Venous Leg Ulcer

Summary

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Venous Leg Ulcers

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NeoThelium FT (HCT/P 361) for people with venous leg ulcer. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNeoThelium FT (HCT/P 361)

NeoThelium FT is a dehydrated wound covering derived from donated human placental tissue.

Locations(2)

MedCentris of Metairie

Metairie, Louisiana, United States

MedCentris of Slidell

Slidell, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07061613

Related Trials

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers

NCT073358614 locations

MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers

NCT0464724011 locations

COMS for Chronic Ulcers Treatment

NCT0652887310 locations

PAW-Hydrogel for Chronic Wound Healing

NCT075411961 location

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

NCT0548958827 locations